Qu Biologics and TransBIOTech Awarded $450K Applied Research and Development Grant Funding
TransBIOTech, a dedicated Applied Research and Technology Center in Quebec that is focused on supporting biotechnology companies and deepening expertise in this sector in Canada, will partner on this work.
- TransBIOTech, a dedicated Applied Research and Technology Center in Quebec that is focused on supporting biotechnology companies and deepening expertise in this sector in Canada, will partner on this work.
- Dr. Shirin Kalyan, Immunologist and Qu’s Vice President of Scientific Innovation, stated, “In partnership with TransBIOTech, we are very pleased to have been awarded this Applied Research and Development grant to support the expansion of our preclinical and translational programs while we [Qu Biologics] focus on completing enrollment of our two important Phase 2 clinical trials currently underway.
- We at TransBIOTech aim to nurture the Canadian biotech ecosystem and to help generate value for innovative Canadian biotechnology companies, such as Qu Biologics.
- Please subscribe here to receive future news and updates from Qu Biologics.